Exact Sciences (NASDAQ: EXAS) files Form 25 to remove listing

Rhea-AI Filing Summary

Exact Sciences Corp notified the Nasdaq Stock Market LLC of a removal of its Common Stock from listing and registration pursuant to Form 25. The exchange certified it complied with 17 CFR 240.12d2-2 and the issuer complied with exchange rules governing voluntary withdrawal.

The filing is an administrative notice of delisting/withdrawal under Section 12(b) of the Exchange Act and does not state transaction amounts, proceeds, or timing beyond the regulatory certification.

Insights

Exchange Compliance Analyst

Routine regulatory delisting notice; administrative compliance confirmed.

The filing records that Nasdaq and the issuer followed the procedures in 17 CFR 240.12d2-2 for voluntary withdrawal and delisting of the issuer's Common Stock. This is a procedural notification required under Section 12(b).

Cash‑flow treatment, effective date, and subsequent listing plans are not disclosed in the excerpt; subsequent filings or exchange notices would state the timing and any transfer mechanics.

Corporate Governance Specialist

Form 25 signals a change in listing status but contains no operational or financial metrics.

The notice certifies compliance with Nasdaq rules and cites the specific rule citations (17 CFR 240.12d2-2). It is limited to the exchange and issuer attesting to procedural conformity.

Investors seeking effects on trading venue, transfer agents, or shareholder procedures should consult later exchange communications or company releases for concrete dates and instructions.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-35092

Issuer:	EXACT SCIENCES CORP
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	5505 Endeavor Lane
	Madison,	WISCONSIN	53719
Telephone number:					+1 608 284-5700

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-03-23	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Exact Sciences (EXAS) filing Form 25 mean?

It means the company and Nasdaq filed a notice to remove EXAS common stock from Nasdaq listing. The exchange and issuer certified compliance with 17 CFR 240.12d2-2, indicating a voluntary listing withdrawal process was followed rather than a suspension or enforcement action.

Will Exact Sciences (EXAS) shares stop trading after Form 25?

This filing itself is an administrative delisting notification, not a trading suspension order. Separate exchange release or company communication will state the effective date and whether trading will move to another market or stop on Nasdaq.

Does the Form 25 disclose proceeds, price, or transaction details for EXAS?

No. The Form 25 excerpt solely certifies procedural compliance for delisting and voluntary withdrawal and does not include any pricing, proceeds, or financing terms related to securities transactions.

Where can shareholders find timing and next steps after EXAS Form 25?

Shareholders should consult subsequent Nasdaq announcements and company notices for effective dates and transfer instructions. The Form 25 excerpt certifies compliance but does not provide the specific effective date or post‑delisting procedures.